The Breast Program - Translational Cancer Resource

Abramson Cancer Center at Penn Medicine1 site in 1 country4,000 target enrollmentJuly 1, 2012

ConditionsBreast Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Breast Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
Enrollment: 4000
Locations: 1
Primary Endpoint: Number of biospecimen collected
Status: Active, not recruiting
Last Updated: 9 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

TRACR will provide a data/biospecimen repository for translational research to better diagnose, prognose, treat and cure breast cancer (and related diseases/treatment conditions). Patients at the Rowan Breast Center will be consented for donation of blood and if available tumor/healthy/archived tissue. Patients will be consented to give permission to use said specimens for future research and to be contacted in the future about other research participation and additional information.

Registry

clinicaltrials.gov

Start Date

July 1, 2012

End Date

July 1, 2030

Last Updated

9 months ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Abramson Cancer Center at Penn Medicine

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•RBC patients with known invasive cancer pre-surgery (greater or equal to 1.5cm) are given priority in recruitment.
•RBC patients with known invasive cancer pre-surgery (less then 1.5cm).
•RBC patients who are postsurgery for invasive breast cancer (performed at UPHS or non-UPHS entities).
•Patients that are of high risk for breast cancer (family history, known deleterious genetic mutation(s)) seeking a prophylactic mastectomy at the breast clinic.
•Only persons who can understand and give informed consent will be eligible to participate in this study. Furthermore, no persons belonging to vulnerable populations with as children (below 18 years of age), fetuses, neonates or prisoners will be recruited in this study. Pregnant women, who are pre-surgery and having surgery for clinical reasons, can still be recruited for tissue and blood collection.

Exclusion Criteria

•Individual who cannot understand and give informed consent (cognitively impaired persons)
•Children (below 18 years of age), fetuses and neonates
•Prisoners